Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives $68.00 Consensus Price Target from Brokerages
Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have given a buy […]
19 Sep 05:58 · The Markets Daily